Thalassemia major is the most common life-threatening genetic disease. Even though long-term supportive care with regular red cell transfusion and intensive chelation therapy may prolong life-expectancy to the fourth decade of life, bone marrow transplantation remains the only curative option. Appropriate supportive care is quite expensive and may not be regularly available in most low-income areas. Without transfusion support children rarely survive beyond 5 years and with transfusions but no chelation therapy life expectancy rarely extends beyond adolescence.

The aim of this project is to provide financial and professional support for HLA-matched transplants in low-risk needy patients to be performed in selected institutions located in different major cities in Pakistan.

Shared vision and principles will be the foundation of each institutional partnership. Consensus agreements and treatment protocols will be under the responsibility of a physician designated by each institution who will act as the local principal investigator and liaison with the Cure2Children Foundation. Publication policies give appropriate recognition and visibility to each participating center and every relevant contribution. 
 

Photo gallery

The travel in Pakistan

Project thalassemia treatment in Pakistan
with the support of